Amalgam Rx, Inc. — Form D

Amalgam Rx, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-03. The offering totals $45.0M, of which $17.4M was reported sold. Industry: Other Health Care.

Offering

Filed: 2023-01-03
Form: D
Accession: 0001667234-23-000001
Industry: Other Health Care
Exemptions: 06b
Total offering: $45.0M
Amount sold: $17.4M
Remaining: $27.6M
Investors: 62
Date of first sale: 2022-12-16
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-469369

Issuer

Name: Amalgam Rx, Inc.
CIK: 0001667234
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 206 ALAPOCAS DRIVE, WILMINGTON, DE, 19803
Phone: 302 983 0001

Officers, directors & promoters (11)

Name	Role	Location
Jeffrey Courtney	Director	Wilmington, DE
Ryan Sysko	Director	Baltimore, MD
Sonny Vu	Director	Tel Aviv, L3
Ryan Sysko	Executive Officer	Baltimore, MD
SONNY P VU	Director	WILMINGTON, DE
JEFFREY P COURTNEY	Director	WILMINGTON, DE
Ryan A Sysko	Director	Wilmington, DE
Ryan A Sysko	Executive Officer	Wilmington, DE
Sarwar A Islam	Director	Wilmington, DE
Ryan Adam Sysko	Director	Wilmington, DE
Ryan Adam Sysko	Executive Officer	Wilmington, DE

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2025-08-15	D	$7.9M	$7.9M
2019-10-08	D	$750K	$650K
2019-05-03	D/A	$2.0M	$1.2M
2019-03-06	D/A	$2.0M	$998K
2017-06-30	D	$2.0M	$95K
2016-03-24	D	$500K	$215K

More